Connect with us

Finance

STAT+: When FDA Rattles Its Sabre, Drug Makers and Universities Start Reporting Overdue Trial Results

Published

on

Over the past eight years, more than 90% of drug makers and universities that received preliminary warnings from U.S. regulators about overdue clinical trial results responded by quickly providing the information to a federal database, a new analysis found.

Using Freedom of Information Act requests, researchers obtained 58 preliminary warnings the FDA sent to clinical trial sponsors — including 32 issued to drug makers — from 2013 through April 2021. Of these, 57 described potential missing trial results and one referred to missing information about registering a clinical trial, according to the analysis, which was published in JAMA.

Continue to STAT+ to read the full story…

Source: statnews.com

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Finance

Unichem Labs Surges 15% on ANDA Nod From USFDA for Aripiprazole Tablets

Published

on

Aripiprazole tablets are indicated for Schizophrenia and Irritability associated with Autistic Disorder

Original Article: business-standard.com

Continue Reading

Finance

PowerGrid Hits Record High, Gains 4%; Stock Has Rallied 18% in Last 3 Weeks

Published

on

PowerGrid has a robust project pipeline worth Rs 27,500 crore and has capitalised around Rs 22,932 crore in the last four quarters, which provides earnings visibility for 2-3 years

Source: business-standard.com

Continue Reading

Finance

Vodafone Idea Surges 21% in Two Days, Stock Nears 52-week High

Published

on

In the past two weeks, the stock has surged 34 per cent after the telecom service provider increased its prepaid tariff by 20-25 per cent from November 25, 2021

Source: business-standard.com

Continue Reading

Trending

AggroNews.com